🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Kiniksa Pharmaceuticals Ltd (KNSA)

NASDAQ
Currency in USD
22.96
-0.06(-0.24%)
Real-time Data

KNSA Income Statement

Advanced Income Statement
Period Ending:
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa38.54220.18270.26
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-+471.24%+22.74%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa9.9446.9789.93
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa28.61173.21180.33
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-+505.45%+4.11%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa74.22%78.67%66.72%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa185.25163.44205.52
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa-156.649.77-25.2
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+0.46%+106.24%-357.81%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-406.38%4.44%-9.32%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa---
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa---
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa---
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa---
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa0.11.258.54
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-156.5411.03-16.65
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa---
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa---
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa-156.5411.03-16.65
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-0.2%+107.04%-251.02%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa-406.13%5.01%-6.16%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa1.39-172.34-30.74
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa-157.92183.3614.08
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa---
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa-157.92183.3614.08
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+2.14%+216.11%-92.32%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-409.72%83.28%5.21%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa---
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa-157.92183.3614.08
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-2.32.640.2
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+11.75%+214.76%-92.39%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-2.32.60.2
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+11.77%+212.9%-92.31%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa68.5869.3870.06
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa68.5870.4271.92
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa---
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa---
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa-154.2812.18-22.86
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+0.44%+107.89%-287.72%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa-400.27%5.53%-8.46%
EBIT
aa.aaaa.aaaa.aaaa.aaaa.aa